rts logo

Positives for Biogen Inc (BIIB) as stock gains in recent trading

Biogen Inc (NASDAQ: BIIB) is -16.67% lower on its value in year-to-date trading and has touched a low of $211.01 and a high of $319.76 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BIIB stock was last observed hovering at around $216.34 in the last trading session, with the day’s loss setting it -0.71%.

Currently trading at $215.63, the stock is -1.97% and -6.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.77 million and changing -0.33% at the moment leaves the stock -14.59% off its SMA200. BIIB registered -20.13% loss for a year compared to 6-month loss of -16.27%. The firm has a 50-day simple moving average (SMA 50) of $3.83 and a 200-day simple moving average (SMA200) of $18.46.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -2.76% gain in the last 1 month and extending the period to 3 months gives it a -17.68%, and is -2.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.99% over the week and 2.13% over the month.

Biogen Inc (BIIB) has around 7570 employees, a market worth around $31.34B and $9.42B in sales. Current P/E ratio is 27.02 and Fwd P/E is 12.19. Profit margin for the company is 12.33%. Distance from 52-week low is 2.19% and -32.57% from its 52-week high. The company has generated returns on investments over the last 12 months (5.28%).

Biogen Inc quarterly earnings per share for the current quarter are estimated at $3.49 with sales reaching $2.32B over the same period.The EPS is expected to grow by 5.54% this year, but quarterly earnings will post -3.70% year-over-year. Quarterly sales are estimated to shrink -1.00% in year-over-year returns.

Biogen Inc (BIIB) Top Institutional Holders

1,465 institutions hold shares in Biogen Inc (BIIB), with institutional investors hold 93.69% of the company’s shares. The shares outstanding are 144.90M, and float is at 144.19M with Short Float at 1.84%. Institutions hold 93.04% of the Float.

The top institutional shareholder in the company is Primecap Management Company with over 16.03 million shares valued at $4.56 billion. The investor’s holdings represent 11.07% of the BIIB Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 14.07 million shares valued at $4.01 billion to account for 9.71% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 12.2 million shares representing 8.42% and valued at over $3.47 billion, while State Street Corporation holds 4.75% of the shares totaling 6.89 million with a market value of $1.96 billion.

Biogen Inc (BIIB) Insider Activity

The most recent transaction is an insider sale by Singhal Priya,the company’sHead of Development. SEC filings show that Singhal Priya sold 262 shares of the company’s common stock on Feb 22 ’24 at a price of $221.23 per share for a total of $57962.0. Following the sale, the insider now owns 4886.0 shares.

Biogen Inc disclosed in a document filed with the SEC on Feb 16 ’24 that Singhal Priya (Head of Development) sold a total of 108 shares of the company’s common stock. The trade occurred on Feb 16 ’24 and was made at $221.49 per share for $23921.0. Following the transaction, the insider now directly holds 5148.0 shares of the BIIB stock.

Still, SEC filings show that on Feb 15 ’24, Rowinsky Eric K (Director) acquired 455 shares at an average price of $222.54 for $0.1 million. The insider now directly holds 20,629 shares of Biogen Inc (BIIB).

Related Posts